Milestone Pharmaceuticals Inc. (MIST) Debt Components
- 2026-06-30: Long-term DebtUSD $59.21M; Debt Instrument, Collateral AmountUSD $900.00K.
- 2026-03-31: Long-term DebtUSD $58.19M; Debt Instrument, Collateral AmountUSD $900.00K.
- 2025-12-31: Long-term DebtUSD $57.19M; Debt Instrument, Collateral AmountUSD (m).
- 2025-12-31: Long-term DebtUSD (m); Debt Instrument, Collateral AmountUSD $900.00K.
Milestone Pharmaceuticals Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt USD | Debt Instrument, Collateral Amount USD |
|---|---|---|
| 2026-06-30 | $59.21M | $900.00K |
| 2026-03-31 | $58.19M | $900.00K |
| 2025-12-31 | $57.19M | (m) |
| 2025-12-31 | (m) | $900.00K |
| 2025-09-30 | $56.21M | $900.00K |
| 2025-06-30 | $55.24M | $900.00K |
| 2025-03-31 | $54.29M | $900.00K |
| 2024-12-31 | $53.35M | (m) |
| 2024-09-30 | $52.43M | $500.00K |
| 2024-06-30 | $51.53M | $500.00K |
| 2024-03-31 | $50.64M | $500.00K |
| 2023-12-31 | $49.77M | (m) |
| 2023-09-30 | $48.91M | (m) |
| 2023-06-30 | $48.07M | (m) |
| 2023-03-31 | $47.32M | (m) |
| 2019-12-31 | $0.00 | (m) |
| 2019-09-30 | $0.00 | (m) |
| 2019-06-30 | $0.00 | (m) |
| 2019-03-31 | $0.00 | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B |